Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Safety and efficacy of fingolimod in clinical practice: The experience of an academic center in the Middle East.
Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM.
The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude.
Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomains.
Viability of autoantibody-targets: How to tackle pathogenetic heterogeneity as an obstacle for treatment of multiple sclerosis.
Acute and subacute inflammation of the optic nerve and its sheath: clinical features in Chinese patients.
Comparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis.
Sildenafil citrate for erectile dysfunction in patients with multiple sclerosis.
Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis.
Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.
Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis.
Multiple Sclerosis Questionnaire for Job Difficulties (MSQ-Job): definition of the cut-off score.
FTY720 (Fingolimod) attenuates basal and sphingosine 1-phosphate-evoked thyroid cancer cell invasion.
Factors related to difficulties with employment in patients with multiple sclerosis: a review of 2002-2011 literature.
Cavernoma of the conus medullaris mimicking transverse myelitis.
Vitamin D and multiple sclerosis: what is the clinical impact?
Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.
PML risk stratification using anti-JCV antibody index and L-selectin.
Imaging of microglia in patients with neurodegenerative disorders.
Diagnostic laboratory testing for Charcot Marie Tooth disease (CMT): the spectrum of gene defects in Norwegian patients with CMT and its implications for future genetic test strategies.
Regulation of claudins in blood-tissue barriers under physiological and pathological states.
Uveitis as a prognostic factor in multiple sclerosis.
Brain MRI abnormalities in Brazilian patients with neuromyelitis optica.
Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy?
One of the oldest patients with Neuromyelitis Optica in the literature.
Pages
« first
‹ previous
…
252
253
254
255
256
257
258
259
260
…
next ›
last »